CN100447319C - Medical protein fiber for preventing and treating proliferation of mammal gland and its preparation method and application - Google Patents
Medical protein fiber for preventing and treating proliferation of mammal gland and its preparation method and application Download PDFInfo
- Publication number
- CN100447319C CN100447319C CNB2006100274596A CN200610027459A CN100447319C CN 100447319 C CN100447319 C CN 100447319C CN B2006100274596 A CNB2006100274596 A CN B2006100274596A CN 200610027459 A CN200610027459 A CN 200610027459A CN 100447319 C CN100447319 C CN 100447319C
- Authority
- CN
- China
- Prior art keywords
- protein
- fiber
- proliferation
- mammary gland
- preventing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
This invention involves one kind of medicinal purposes protein textile fiber which is used for preventing and curing hyperplasia of mammary glands, and the process and application. The compound according to textile fiber gross is as follows: percentage A is protein, percentage B is high polymer, percentage C is medicine, percentage D is medicine that passes the skin absorption promoter, and the percentage is: 1<=A<=80,1<=B<=80,0<C <=20,0<D<=10. Among them, the high polymer is a kind of or a combination of polyvinyl alcohol, polyacrylonitrile, cellulose, polyvinyl acetate; the medicine can be one or a combination of xifen, isoflavone, bromocriptine and danazol; the medicine skin penetration enhancer can also be one or a combination of nitrogen alkone, oleic acid, N- methyl - 2- pyrrolidone, trimethylene glycol, or borneol.
Description
Technical field
The present invention relates to a kind of medicinal fibre, especially a kind of medical protein fiber of preventing and treating the proliferation of mammary gland, and manufacture method and application.
Background technology
The proliferation of mammary gland is modal breast disease, and its incidence of disease accounts for the first place of mammary gland disease, and the incidence of disease improves day by day and gradually in rejuvenation, the proliferation of mammary gland has the danger of potential generation breast cancer.To the treatment of the proliferation of mammary gland, general oral or some dispersing stagnated hepatoqis of external application of the traditional Chinese medical science, Chinese medicine promoting blood circulation and removing blood stasis; Doctor trained in Western medicine is then selected hormone medicine or operative treatment for use.This sick effect of Chinese traditional treatment is better, but traditional Chinese medical science oral medication is loaded down with trivial details owing to decocting medicinal herbs, and administration time is long, and patient is difficult to adhere to that this sick curative effect of western medical treatment is not obvious, and side effect is big.No matter be the traditional Chinese medical science or doctor trained in Western medicine, patient wants frequent discrepancy hospital and frequent medication every day, has wasted a large amount of time and efforts, and has brought the misery of body and mind to the patient.Go if the medicine of preventing and treating the proliferation of mammary gland can be added in the brassiere, medicine is slowly released in the process of the daily wearing brassiere of people, effect and breast, thereby reach the purpose of preventing and treating the proliferation of mammary gland, just not only can avoid inconvenience that traditional methods of treatment brings to patient and painful, also comply with the development trend that present inner disease outer treat and treatment medical science turn to prevention and physical-fitness medicine.Yet there are no at present the report of this series products abroad, domestic existing relevant like product pastes as medicine brassiere and breast pain.
The shortcoming that present medicinal bra and breast pain are pasted mainly shows the following aspects:
1, medicinal bra
(1) medication inconvenience.Present medicine brassiere adopts the Chinese medicine medicine bag directly to spread on the affected part, need frequently decoct medicinal herbs, and changes dressings;
(2) smell is big.Because be to adopt the direct external application of medicine or adopt the fabric that directly will be dipped in soup, smell is big, has influenced patient's daily life;
(3) feel is poor.Because be the fabric that adopts the immersion of soup, fabric is coarse, and is stiff, feel is poor, and dress does not feel like oneself.
2, the breast pain is pasted
(1) gas permeability is poor, and skin has sultry sense;
(2) allergic possibility is arranged;
(3) influence is attractive in appearance, does not meet modern's aesthetic requirement.
Summary of the invention
The objective of the invention is to: provide a kind of medical protein fiber, to overcome the existing big defective of medicinal fabric smell.
A further object of the present invention provides a kind of method for preparing medical protein fiber, and makes full use of existing equipment as much as possible.
Another purpose of the present invention provides a kind of using method of medical protein fiber.
The object of the invention can be achieved through the following technical solutions: a kind of medical protein fiber of preventing and treating the proliferation of mammary gland, contain protein, high molecular polymer, prevent and treat the medicine and the drug transdermal sorbefacient of the proliferation of mammary gland, wherein, described protein is a kind of or its composition in phytoprotein, the animal protein; Described high molecular polymer is one or more in polyvinyl alcohol, polyacrylonitrile, third rare nitrile, cellulose, the vinyl acetate; Described medicine is included as a kind of or its composition in tamoxifen (TAM), isoflavones (isoflavones), Bromocriptine (bromocriPtine) and the danazol (danazol); Described drug transdermal sorbefacient is a kind of or its composition in azone, oleic acid, N-N-methyl-2-2-pyrrolidone N-, propylene glycol, the borneol; Protein accounts for A part of total weight of fiber, and high molecular polymer accounts for B part of total weight of fiber, and medicine accounts for C part of total weight of fiber, and the drug transdermal sorbefacient accounts for D part of total weight of fiber, then: 1≤A≤80,1≤B≤80,0＜C≤20,0＜D≤10.
On the such scheme basis, described protein is animal protein, and animal protein accounts for A part of total weight of fiber, 1≤A≤80.
Perhaps, described protein is phytoprotein, and phytoprotein accounts for A part of total weight of fiber, 1≤A≤80.
Also can be, described protein be the mixture of phytoprotein and animal protein, and the total amount of phytoprotein and animal protein accounts for A part of total weight of fiber, 1≤A≤80, and wherein phytoprotein accounts for E part of protein gross weight, 1≤E≤99.
Protein fibre of the present invention can be natural protein fibre.
The invention provides a kind of preparation method who prevents and treats the medical protein fiber of the proliferation of mammary gland, comprising: the first step, make spinning solution by protein, high molecular polymer, the medicine of preventing and treating the proliferation of mammary gland and drug transdermal sorbefacient; In second step, make a kind of medical protein fiber of preventing and treating the proliferation of mammary gland by this spinning solution.
In the inventive method, described medicine and the drug transdermal sorbefacient of preventing and treating the proliferation of mammary gland adds proteinaceous spinning solution, and stir, wherein, the solid amount of doing of proliferation of mammary gland medicine of preventing and treating that adds is C part, 0＜C≤20, the solid amount of doing of the drug transdermal sorbefacient of adding is D part, 0＜D≤10.
On the said method basis, a kind of preparation method who prevents and treats the medical protein fiber of the proliferation of mammary gland is: in second step, the method that adopts when making fiber by spinning solution is wet spinning technology, dry-spinning process or dry-jet wet spinning process.
The medical protein fiber of preventing and treating the proliferation of mammary gland of the present invention can be used for making the cloth of the pharmacologic action with the proliferation of mammary gland of preventing and treating, and this cloth can be attached to the internal layer or the endosexine of brassiere as the internal layer lining of brassiere.
Concrete using method is: according to the requirement of fabric index parameters such as the fabric structure of common brassiere internal layer lining, Density, the medical protein fiber of preventing and treating the proliferation of mammary gland is made into cloth, then, as brassiere internal layer lining, make medicinal bra with this cloth according to the manufacturing process and the method for common brassiere.
The present invention has following advantage: 1, manufacture craft is simple, is easy to realize; 2, raw material sources are abundant, and are with low cost; 3, the brassiere made from the medical protein fiber cloth of preventing and treating the proliferation of mammary gland is prevented and treated the proliferation of mammary gland, and medication is convenient, side effect is little, and does not influence patient's external beauty, meets very much the hommization demand that modern female is cured the disease and pursued beauty.
Specific embodiment
A kind of medical protein fiber of preventing and treating the proliferation of mammary gland, by the percentage composition that accounts for total weight of fiber is the protein of A part, the percentage composition that accounts for total weight of fiber is the high molecular polymer of B part, the percentage composition that accounts for total weight of fiber is the medicine of C part, the percentage composition that accounts for total weight of fiber is that the drug transdermal sorbefacient of D part is formed, then: 1≤A≤80,1≤B≤80,0＜C≤20,0＜D≤10, wherein, described high molecular polymer is one or more the composition in polyvinyl alcohol, polyacrylonitrile, cellulose, the polyvinyl acetate; Described medicine can be more than one composition of a kind of in tamoxifen, isoflavones, Bromocriptine and the danazol or its; Described drug transdermal sorbefacient can be more than one composition of a kind of in azone, oleic acid, N-N-methyl-2-2-pyrrolidone N-, propylene glycol, the borneol or its.
Medical protein fiber of specifically preventing and treating the proliferation of mammary gland and its production and use is exemplified below:
Embodiment 1:
The first step, the preparation spinning solution.The spinning solution that contains earlier protein and high molecular polymer by existing prepared, wherein, it is 50 weight portions that the doing of protein measured A admittedly, it is 49 weight portions that the doing of high molecular polymer measured B admittedly.To prevent and treat the medicine of the proliferation of mammary gland and drug transdermal sorbefacient then adds in this spinning solution and stirs, admittedly to measure C be 0.5 weight portion to the doing of proliferation of mammary gland medicine of preventing and treating that adds, and it is 0.5 weight portion that the doing of the drug transdermal sorbefacient of adding measured D admittedly;
Second step, to contain the spinning solution of preventing and treating proliferation of mammary gland medicine and drug transdermal sorbefacient and make medical protein fiber, adopt wet spinning technology, dry-spinning process or dry-jet wet spinning process all can, both contain protein in the medical protein fiber of making, contained medicine and the drug transdermal sorbefacient of preventing and treating the proliferation of mammary gland again;
Be made into cloth with the medical protein fiber of making, and make brassiere as the internal layer lining of brassiere, then both contained protein in the internal layer lining of brassiere, contain medicine and the drug transdermal sorbefacient of preventing and treating the proliferation of mammary gland again with this cloth.
In the present embodiment, preventing and treating the protein that contains in the medicinal fibre of the proliferation of mammary gland can be animal protein, also can be phytoprotein.
In the present embodiment, high molecular polymer can be one or more in polyvinyl alcohol, polyacrylonitrile, third rare nitrile, cellulose, the polyvinyl acetate.
In the present embodiment, the medicine of preventing and treating the proliferation of mammary gland can be a kind of in the clinical already used medicine of preventing and treating the proliferation of mammary gland of tamoxifen (TAM), isoflavones (isoflavones), Bromocriptine (bromocriPtine), danazol (danazol) or other.
In the present embodiment, the drug transdermal sorbefacient can be a kind of in azone, oleic acid, N-N-methyl-2-2-pyrrolidone N-, propylene glycol, borneol or the other medicines skin penetration enhancer.
In the present embodiment, the medical protein fiber of preventing and treating the proliferation of mammary gland is made into the operation of cloth, adopts the weaving process of existing brassiere internal layer lining.
In the present embodiment, adopt the production process of common brassiere to make brassiere, its internal layer cloth that the medical protein fiber of preventing and treating the proliferation of mammary gland is made into of serving as reasons.
Embodiment 2:
In the present embodiment, in the spinning solution protein do that to measure A admittedly be 80 weight portions, it is 15 weight portions that the doing of high molecular polymer measured B admittedly, preventing and treating doing of proliferation of mammary gland medicine, to measure C admittedly be 4 weight portions, it is 1 weight portion that the doing of drug transdermal sorbefacient measured D admittedly, and other method is identical with embodiment 1.
Embodiment 3:
In the present embodiment, in the spinning solution protein do that to measure A admittedly be 30 weight portions, it is 60 weight portions that the doing of high molecular polymer measured B admittedly, preventing and treating doing of proliferation of mammary gland medicine, to measure C admittedly be 8 weight portions, it is 2 weight portions that the doing of drug transdermal sorbefacient measured D admittedly, and other method is identical with embodiment 1.
Embodiment 4:
In the present embodiment, in the spinning solution protein do that to measure A admittedly be 20 weight portions, it is 75 weight portions that the doing of high molecular polymer measured B admittedly, preventing and treating doing of proliferation of mammary gland medicine, to measure C admittedly be 2.5 weight portions, it is 2.5 weight portions that the doing of drug transdermal sorbefacient measured D admittedly, and other method is identical with embodiment 1.
Embodiment 5:
In the present embodiment, in the spinning solution protein do that to measure A admittedly be 10 weight portions, it is 80 weight portions that the doing of high molecular polymer measured B admittedly, preventing and treating doing of proliferation of mammary gland medicine, to measure C admittedly be 5.5 weight portions, it is 4.5 weight portions that the doing of drug transdermal sorbefacient measured D admittedly, and other method is identical with embodiment 1.
Embodiment 6:
In the present embodiment, in the spinning solution protein do that to measure A admittedly be 40 weight portions, it is 40 weight portions that the doing of high molecular polymer measured B admittedly, preventing and treating doing of proliferation of mammary gland medicine, to measure C admittedly be 16 weight portions, it is 4 weight portions that the doing of drug transdermal sorbefacient measured D admittedly, and other method is identical with embodiment 1.
Embodiment 7:
In the present embodiment, in the spinning solution protein do that to measure A admittedly be 70 weight portions, it is 15 weight portions that the doing of high molecular polymer measured B admittedly, preventing and treating doing of proliferation of mammary gland medicine, to measure C admittedly be 9.5 weight portions, it is 5.5 weight portions that the doing of drug transdermal sorbefacient measured D admittedly, and other method is identical with embodiment 1.
Embodiment 8:
In the present embodiment, protein does that to measure A admittedly be 42.5 weight portions in the spinning solution, it is 37.5 weight portions that the doing of high molecular polymer measured B admittedly, preventing and treating doing of proliferation of mammary gland medicine, to measure C admittedly be 18.5 weight portions, it is 1.5 weight portions that the doing of drug transdermal sorbefacient measured D admittedly, and other method is identical with embodiment 1.
Embodiment 9:
In the present embodiment, protein does that to measure A admittedly be 39.5 weight portions in the spinning solution, it is 47.5 weight portions that the doing of high molecular polymer measured B admittedly, preventing and treating doing of proliferation of mammary gland medicine, to measure C admittedly be 3.5 weight portions, it is 9.5 weight portions that the doing of drug transdermal sorbefacient measured D admittedly, and other method is identical with embodiment 1.
Embodiment 10:
In the present embodiment, in the spinning solution protein do that to measure A admittedly be 25 weight portions, it is 70 weight portions that the doing of high molecular polymer measured B admittedly, preventing and treating doing of proliferation of mammary gland medicine, to measure C admittedly be 1.5 weight portions, it is 3.5 weight portions that the doing of drug transdermal sorbefacient measured D admittedly, and other method is identical with embodiment 1.
Embodiment 11:
In the present embodiment, in the spinning solution protein do that to measure A admittedly be 60 weight portions, it is 20 weight portions that the doing of high molecular polymer measured B admittedly, preventing and treating doing of proliferation of mammary gland medicine, to measure C admittedly be 12.5 weight portions, it is 7.5 weight portions that the doing of drug transdermal sorbefacient measured D admittedly, and other method is identical with embodiment 1.
Embodiment 12:
In the present embodiment, the protein that contains in the spinning solution is the mixture of animal protein and phytoprotein, in the mixture of two kinds of protein, it is 1 weight portion that the doing of phytoprotein measured E admittedly, mixed protein total does and measure A admittedly is 50 weight portions, and it is 49 weight portions that the doing of high molecular polymer measured B admittedly, and preventing and treating doing of proliferation of mammary gland medicine, to measure C admittedly be 0.5 weight portion, it is 0.5 weight portion that the doing of drug transdermal sorbefacient measured D admittedly, and other method is identical with embodiment 1.
Embodiment 13:
In the present embodiment, protein does that to measure A admittedly be 80 weight portions in the spinning solution, phytoprotein accounts for doing of protein to measure E admittedly is 99 weight portions in the protein, it is 15 weight portions that the doing of high molecular polymer measured B admittedly, preventing and treating doing of proliferation of mammary gland medicine, to measure C admittedly be 4 weight portions, it is 1 weight portion that the doing of drug transdermal sorbefacient measured D admittedly, and other method is identical with embodiment 1.
Embodiment 14:
In the present embodiment, protein does that to measure A admittedly be 30 weight portions in the spinning solution, wherein phytoprotein accounts for doing of protein to measure E admittedly is 50 weight portions, it is 60 weight portions that the doing of high molecular polymer measured B admittedly, preventing and treating doing of proliferation of mammary gland medicine, to measure C admittedly be 8 weight portions, it is 2 weight portions that the doing of drug transdermal sorbefacient measured D admittedly, and other method is identical with embodiment 1.
Embodiment 15:
In the present embodiment, protein does that to measure A admittedly be 20 weight portions in the spinning solution, wherein phytoprotein accounts for doing of protein to measure E admittedly is 25 weight portions, it is 75 weight portions that the doing of high molecular polymer measured B admittedly, preventing and treating doing of proliferation of mammary gland medicine, to measure C admittedly be 2.5 weight portions, it is 2.5 weight portions that the doing of drug transdermal sorbefacient measured D admittedly, and other method is identical with embodiment 1.
Embodiment 16:
In the present embodiment, protein does that to measure A admittedly be 10 weight portions in the spinning solution, wherein phytoprotein accounts for doing of protein to measure E admittedly is 75 weight portions, it is 80 weight portions that the doing of high molecular polymer measured B admittedly, preventing and treating doing of proliferation of mammary gland medicine, to measure C admittedly be 5.5 weight portions, it is 4.5 weight portions that the doing of drug transdermal sorbefacient measured D admittedly, and other method is identical with embodiment 1.
Embodiment 17:
In the present embodiment, protein does that to measure A admittedly be 40 weight portions in the spinning solution, wherein phytoprotein accounts for doing of protein to measure E admittedly is 15 weight portions, it is 40 weight portions that the doing of high molecular polymer measured B admittedly, preventing and treating doing of proliferation of mammary gland medicine, to measure C admittedly be 16 weight portions, it is 4 weight portions that the doing of drug transdermal sorbefacient measured D admittedly, and other method is identical with embodiment 1.
Embodiment 18:
In the present embodiment, protein does that to measure A admittedly be 70 weight portions in the spinning solution, phytoprotein does that to measure E admittedly be 85 weight portions in the protein, it is 15 weight portions that the doing of high molecular polymer measured B admittedly, preventing and treating doing of proliferation of mammary gland medicine, to measure C admittedly be 9.5 weight portions, it is 5.5 weight portions that the doing of drug transdermal sorbefacient measured D admittedly, and other method is identical with embodiment 1.
Embodiment 19:
In the present embodiment, protein does that to measure A admittedly be 42.5 weight portions in the spinning solution, wherein phytoprotein accounts for doing of protein to measure E admittedly is 55 weight portions, it is 37.5 weight portions that the doing of high molecular polymer measured B admittedly, preventing and treating doing of proliferation of mammary gland medicine, to measure C admittedly be 18.5 weight portions, it is 1.5 weight portions that the doing of drug transdermal sorbefacient measured D admittedly, and other method is identical with embodiment 1.
Embodiment 20:
In the present embodiment, protein does that to measure A admittedly be 39.5 weight portions in the spinning solution, wherein phytoprotein accounts for doing of protein to measure E admittedly is 45 weight portions, it is 47.5 weight portions that the doing of high molecular polymer measured B admittedly, preventing and treating doing of proliferation of mammary gland medicine, to measure C admittedly be 3.5 weight portions, it is 9.5 weight portions that the doing of drug transdermal sorbefacient measured D admittedly, and other method is identical with embodiment 1.
Embodiment 21:
In the present embodiment, protein does that to measure A admittedly be 25 weight portions in the spinning solution, phytoprotein does that to measure E admittedly be 80 weight portions in the protein, it is 70 weight portions that the doing of high molecular polymer measured B admittedly, preventing and treating doing of proliferation of mammary gland medicine, to measure C admittedly be 1.5 weight portions, it is 3.5 weight portions that the doing of drug transdermal sorbefacient measured D admittedly, and other method is identical with embodiment 1.
Embodiment 22:
In the present embodiment, protein does that to measure A admittedly be 60 weight portions in the spinning solution, phytoprotein does that to measure E admittedly be 20 weight portions in the protein, it is 20 weight portions that the doing of high molecular polymer measured B admittedly, preventing and treating doing of proliferation of mammary gland medicine, to measure C admittedly be 12.5 weight portions, it is 7.5 weight portions that the doing of drug transdermal sorbefacient measured D admittedly, and other method is identical with embodiment 1.
Claims (9)
1. medical protein fiber of preventing and treating the proliferation of mammary gland, by the percentage composition that accounts for total weight of fiber is the protein of A part, the percentage composition that accounts for total weight of fiber is the high molecular polymer of B part, the percentage composition that accounts for total weight of fiber is the medicine of C part, the percentage composition that accounts for total weight of fiber is that the drug transdermal sorbefacient of D part is formed, then: 1≤A≤80,1≤B≤80,0＜C≤20,0＜D≤10, wherein, described high molecular polymer is one or more the composition in polyvinyl alcohol, polyacrylonitrile, cellulose, the polyvinyl acetate; Described medicine can be more than one composition of a kind of in tamoxifen, isoflavones, Bromocriptine and the danazol or its; Described drug transdermal sorbefacient can be more than one composition of a kind of in azone, oleic acid, N-N-methyl-2-2-pyrrolidone N-, propylene glycol, the borneol or its.
2. a kind of medical protein fiber of preventing and treating the proliferation of mammary gland according to claim 1 is characterized in that: described protein is animal protein, and animal protein accounts for A part of total weight of fiber, 1≤A≤80.
3. a kind of medical protein fiber of preventing and treating the proliferation of mammary gland according to claim 1 is characterized in that: described protein is phytoprotein, and phytoprotein accounts for A part of total weight of fiber, 1≤A≤80.
4. a kind of medical protein fiber of preventing and treating the proliferation of mammary gland according to claim 1, it is characterized in that: described protein is the mixture of phytoprotein and animal protein, the total amount of phytoprotein and animal protein accounts for A part of total weight of fiber, 1≤A≤80, wherein phytoprotein accounts for E part of protein gross weight, 1≤E≤99.
5. according to the described preparation method who prevents and treats the medical protein fiber of the proliferation of mammary gland of one of claim 1 to 4, comprise the steps: the first step, by the percentage composition that accounts for total weight of fiber is protein 1≤A≤80 of A part, the percentage composition that accounts for total weight of fiber is high molecular polymer 1≤B≤80 of B part, the percentage composition that accounts for total weight of fiber is medicine 0＜C≤20 of C part, and the percentage composition that accounts for total weight of fiber is that drug transdermal sorbefacient 0＜D≤10 of D part are mixed and made into spinning solution; In second step, make a kind of medical protein fiber of preventing and treating the proliferation of mammary gland through spinning by this spinning solution.
6. the preparation method who prevents and treats the medical protein fiber of the proliferation of mammary gland according to claim 5, it is characterized in that: described medicine and the adding of drug transdermal sorbefacient that prevents and treats the proliferation of mammary gland contains the spinning solution of protein and high molecular polymer, and stirs.
7. a kind of preparation method who prevents and treats the medical protein fiber of the proliferation of mammary gland according to claim 5, it is characterized in that: in second step, the method that adopts when making fiber by spinning solution is, a kind of in wet spinning technology, dry-spinning process or the dry-jet wet spinning process.
8. purposes of preventing and treating the medical protein fiber of the proliferation of mammary gland according to claim 1 is used to make and has the medicinal cloth of preventing and treating proliferation of mammary gland effect.
9. purposes of preventing and treating the medical protein fiber of the proliferation of mammary gland according to claim 8 is characterized in that: described internal layer lining with medicinal cloth of preventing and treating proliferation of mammary gland effect as brassiere.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100274596A CN100447319C (en) | 2006-06-08 | 2006-06-08 | Medical protein fiber for preventing and treating proliferation of mammal gland and its preparation method and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100274596A CN100447319C (en) | 2006-06-08 | 2006-06-08 | Medical protein fiber for preventing and treating proliferation of mammal gland and its preparation method and application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1904158A CN1904158A (en) | 2007-01-31 |
| CN100447319C true CN100447319C (en) | 2008-12-31 |
Family
ID=37673516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100274596A Active CN100447319C (en) | 2006-06-08 | 2006-06-08 | Medical protein fiber for preventing and treating proliferation of mammal gland and its preparation method and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100447319C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105297174B (en) * | 2015-11-16 | 2017-07-21 | 安徽绿朋环保科技股份有限公司 | A kind of soybean fiber and production technology |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1378445A (en) * | 1999-08-06 | 2002-11-06 | 得克萨斯***大学评议会 | Drug releasing biodegradable fiber implant |
| WO2004054372A2 (en) * | 2002-12-13 | 2004-07-01 | Kalle Gmbh & Co. Kg | Spinning material for the production of edible food casings |
| CN1569319A (en) * | 2004-05-10 | 2005-01-26 | 浙江大学 | Polyacrylonitrile/maleic acid hollow fibre film and its preparation method and use |
| US20050079201A1 (en) * | 2003-05-28 | 2005-04-14 | Jorg Rathenow | Implants with functionalized carbon surfaces |
| CN1768731A (en) * | 2005-09-06 | 2006-05-10 | 东华大学 | Medicinal bra for preventing and treating mammary glands hyperplasia and its preparation method |
-
2006
- 2006-06-08 CN CNB2006100274596A patent/CN100447319C/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1378445A (en) * | 1999-08-06 | 2002-11-06 | 得克萨斯***大学评议会 | Drug releasing biodegradable fiber implant |
| WO2004054372A2 (en) * | 2002-12-13 | 2004-07-01 | Kalle Gmbh & Co. Kg | Spinning material for the production of edible food casings |
| US20050079201A1 (en) * | 2003-05-28 | 2005-04-14 | Jorg Rathenow | Implants with functionalized carbon surfaces |
| CN1569319A (en) * | 2004-05-10 | 2005-01-26 | 浙江大学 | Polyacrylonitrile/maleic acid hollow fibre film and its preparation method and use |
| CN1768731A (en) * | 2005-09-06 | 2006-05-10 | 东华大学 | Medicinal bra for preventing and treating mammary glands hyperplasia and its preparation method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1904158A (en) | 2007-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106418739B (en) | A kind of antibiotic multifunction graphene Woman health underpants and preparation method thereof | |
| CN103263696B (en) | Novel catgut implantation at acupoint and preparation method thereof | |
| CN100447319C (en) | Medical protein fiber for preventing and treating proliferation of mammal gland and its preparation method and application | |
| CN100447320C (en) | Medicinal chitin fiber for preventing mammary gland hyperplasia, and its preparation and use | |
| CN101757347B (en) | Clinopodium polycephalum band-aid and preparation method thereof | |
| TW200942270A (en) | Chinese medicine composition for treatment of wounds or bedsore, and method for producing preparation thereof | |
| CN101669986A (en) | Compound gel preparation containing sophora alopecuroide oil | |
| CN106362190A (en) | Multifunctional graphene sanitary towel capable of promoting blood circulation and preparation method thereof | |
| CN100503909C (en) | Pharmaceutical polyacrylonitrile fiber for preventing and curing mammary gland hyperplasia, preparation and application thereof | |
| CN101148785B (en) | Gromwell root medical polypropylene fibre for preventing and curing skin disease, preparation method and application thereof | |
| CN105962430A (en) | Traditional Chinese medicine nanometer sock manufacture method | |
| CN203063203U (en) | Composite paper containing folium artemisiae argyi or other Chinese herbal medicine components | |
| CN100446760C (en) | Medicated chitin fiber for treating and preventing proliferation of mammary gland, prepn. method and application thereof | |
| CN106581732A (en) | Multifunctional graphene sanitary towel and preparation method thereof | |
| CN216258442U (en) | Hyaluronic acid dressing suitable for different skin states | |
| CN101444597B (en) | Chinese herbal medicine for treating tumor | |
| CN113509509B (en) | Traditional Chinese medicine emplastrum for reducing hyperglycemia and preparation method thereof | |
| CN2093643U (en) | Herb-containing medical dressing | |
| CN201058075Y (en) | Pain relieving tape for bosom urosome tumour patient | |
| CN101574504B (en) | Medical composition for treating mammary gland diseases and preparation method thereof | |
| CN2229266Y (en) | External using plaster for treating hyperplasia of mammary glands | |
| CN206659125U (en) | A kind of novel antibacterial deodorization socks | |
| CN202314992U (en) | Magnetic far-infrared-based outer ankle sleeping acupoint plaster | |
| CN106360814B (en) | A kind of Woman health underpants for improving dysmenorrhoea enhancing sexual function and preparation method thereof | |
| CN1569079A (en) | Externally applied medicament for treating mammary gland disease and its preparing method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: ZHU LIMIN Free format text: FORMER OWNER: LIFANGJIAN MEDICAL TECHNOLOGY CONSULTING (SHANGHAI) CO., LTD. Effective date: 20090911 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20090911 Address after: 25A, 99, 18 East Nandan Road, Shanghai, Xuhui District Patentee after: Zhu Limin Address before: Shanghai City, No. 6555 humin Road 16 floor Patentee before: Lifangjian Medical Sci. & Tech. Consulting (Shanghai) Co., Ltd. |
|
| ASS | Succession or assignment of patent right |
Owner name: ZHEJIANG YIWU LIFU SPINNING CO., LTD. Free format text: FORMER OWNER: ZHU LIMIN Effective date: 20100108 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20100108 Address after: No. 308, FA FA Avenue, Yiwu Economic Development Zone, Zhejiang Patentee after: Zhejiang Yiwu two Textile Co. Address before: 25A, 99, 18 East Nandan Road, Shanghai, Xuhui District Patentee before: Zhu Limin |
|
| C56 | Change in the name or address of the patentee | ||
| CP01 | Change in the name or title of a patent holder |
Address after: 322000, Zhejiang, Yiwu province (Economic Development Zone) 308 Patentee after: Yiwu two Textile Co. Address before: 322000, Zhejiang, Yiwu province (Economic Development Zone) 308 Patentee before: Zhejiang Yiwu two Textile Co. |